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Abstract
Phosphate is required for many important cellular processes and having too little phosphate or too much can cause disease
and reduce life span in humans. However, the mechanisms underlying homeostatic control of extracellular phosphate levels
and cellular effects of phosphate are poorly understood. Here, we establish Drosophila melanogaster as a model system for
the study of phosphate effects. We found that Drosophila larval development depends on the availability of phosphate in
the medium. Conversely, life span is reduced when adult flies are cultured on high phosphate medium or when hemolymph
phosphate is increased in flies with impaired Malpighian tubules. In addition, RNAi-mediated inhibition of MAPK-signaling
by knockdown of Ras85D, phl/D-Raf or Dsor1/MEK affects larval development, adult life span and hemolymph phosphate,
suggesting that some in vivo effects involve activation of this signaling pathway by phosphate. To identify novel genetic
determinants of phosphate responses, we used Drosophila hemocyte-like cultured cells (S2R+) to perform a genome-wide
RNAi screen using MAPK activation as the readout. We identified a number of candidate genes potentially important for the
cellular response to phosphate. Evaluation of 51 genes in live flies revealed some that affect larval development, adult life
span and hemolymph phosphate levels.
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Introduction
Inorganic phosphate, the mono- or divalent anion of phosphoric
acid [HPO4
32, H2PO4
22], is required for cellular functions such
as DNA and membrane lipid synthesis, generation of high-energy
phosphate esters, and intracellular signaling. Cells and organisms
have developed elaborate mechanisms to assure an adequate
supply of phosphate. Yeast is the only eukaryote, however, in
which the genetics of cellular phosphate homeostasis is understood
[1]. When yeast cells are starved of phosphate, the phosphate-
dependent cyclin-dependent-kinase (CDK) inhibitor Pho81 inacti-
vates the Pho80/Pho85 cyclin/CDK complex. As a consequence
the unphosphorylated basic helix-loop-helix transcription factor
Pho4 associates with the nuclear import receptor Pse1 to enter the
nucleus and binds to a phosphate response element (PRE) [2] in
genes belonging to the yeast Pho-regulon that permit the cell to
better assimilate phosphate from the surroundings [3,4]. The Pho-
regulon includes genes coding for high affinity phosphate
transporters (Pho84, Pho89) and secreted acid phosphatases (Pho5,
Pho11, Pho12) [3].
Compared to what is known for bacteria and yeast, little is
known about the metabolic effects of phosphate in metazoan
species [5,6]. Recent evidence suggests that the mammalian
ortholog of yeast Pho89, Pit1, mediates cellular effects of phosphate
[7], which can be blocked by the addition of phosphonoformic
acid (PFA), a competitive antagonist of phosphate transporters and
cellular phosphate uptake [8,9]. In addition, we recently showed
that orthologs of yeast Pho84 mediate activation of MAPK in
Drosophila cell lines [10]. Thus, multiple membrane transporter
families may be involved in cellular phosphate uptake and
intracellular phosphate may be what is sensed in metazoan
species. Activation of MAPK by inorganic phosphate at physio-
logical concentrations between 5–10 mM was also demonstrated
in multiple mammalian cell lines [7,11,12,13,14] and may be
required for osteoblastic and chondrogenic differentiation, or
pathological osteogenic differentiation of vascular smooth muscle
cells in response to phosphate [5,6].
In multicellular organisms phosphate needs to be absorbed from
the diet in the gut to enter the circulation and to be available for
cells. Circulating phosphate levels, total body phosphate content
and excretion by the kidneys are tightly regulated by a number of
hormones. In mammals these hormones are fibroblast growth factor
23 (FGF23), parathyroid hormone (PTH), and 1,25-dihydroxy vitamin D
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(1,25(OH)2D) [6,15] and genetic or acquired disturbances of these
regulatory mechanisms can result in serious human disorders [15].
Serum phosphate feeds back to regulate these factors in
a homeostatic fashion [15], with high phosphate increasing the
secretion of PTH and FGF23 and low phosphate stimulating the
synthesis of 1,25(OH)2D, the active form of vitamin D [6].
However, it remains unclear, whether activation of MAPK by
phosphate has a role in the homeostatic regulation of FGF23, PTH
or 1,25(OH)2D at the level of gene expression [16].
The clinical consequences of severe hypophosphatemia (too
little phosphate), which for example are seen in conditions of
malnutrition or tumor-induced hypophosphatemia [17], include
hemolysis, skeletal muscle myopathy, cardiomyopathy, neuropa-
thy, and osteomalacia and, in some cases, contribute to death. On
the other hand, hyperphosphatemia (too much phosphate) due to
familial tumoral calcinosis [18] or chronic kidney disease (CKD)
leads to tissue calcifications [19] and metabolic changes, which to
date are poorly understood. Outcomes in patients with CKD and
hyperphosphatemic mouse models can be improved by dietary
phosphate restriction or treatment with phosphate binders such as
sevelamer (Renagel), which reduce phosphate absorption from the
diet and normalize circulating phosphate levels [20,21]. Thus,
gaining an understanding of the specific pathways and mediators
that regulate cellular and extracellular phosphate levels might lead
to the development of improved dietary or therapeutic approaches
to the treatment of both hypo- and hyperphosphatemia.
Here, we show that Drosophila melanogaster can be used as a model
organism to design genetic screens for metabolic and homeostatic
phosphate effects and describe the effects of in vivo RNAi-mediated
knockdown of 51 modifiers of phosphate-induced MAPK in S2R+
cells on larval development, adult hemolymph phosphate and life
span.
Methods
Fly Stocks and Culture
Fly stocks were cultured as described in Methods S1 on
standard medium (SM) or defined medium (DM) [22] to which
30 mM sodium-phosphate (pH 6.0), 30 mM sodium-sulfate
(pH 6.0), 0.1–10 mM phosphonoformic acid (Sigma P6801), or
0.1–3% sevelamer (gift from Dr. Yves Sabbagh, Genzyme, Inc.,
[23]) were added. Sevelamer is an FDA-approved drug that is used
in patients with CKD to reduce absorption of dietary phosphate.
The soluble fraction of phosphate in SM is about 3.7 mg/dl
(1.2 mM), when measured as ammonium-molybdate adduct using
the Liqui-Phospho UV reagent (Standbio Laboratory, TX).
Supplementation of this medium with 1% sevelamer reduced the
fraction of soluble inorganic phosphate to 0.16 mg/dl (0.05 mM).
Supplementation with 30 mM sodium phosphate (pH 6.0) raised
the soluble inorganic phosphate to 110 mg/dl (35 mM). As
changes in osmolarity, caused by the addition of increasing
amounts of phosphate, might lead to defects that are not specific to
phosphate, but for example due to osmolar stress, we performed
tests with sulfate alongside with phosphate. Finally, dye-feeding
assays [24] were used to confirm similar consumption of the
different foods.
Larval Development, Life Span and Hemolymph
Phosphate Assays
To evaluate wild-type larval development 20 mated females
were allowed to lay approximately 100 eggs for 2 days. Adults
were discarded and culture was continued at 18uC, 25uC, or at
29uC. Near the middle of the L3 stage, vials were inspected daily
to determine the number of animals at different developmental
stages (i.e. climbing L3 larva, prepupa, pupa, adult fly male/
female).
Life span was evaluated by culturing 30–40 young adults
separated by gender on SM or DM with different supplements as
described in Methods S1. In initial tests comparing males and
females, we were able to rule out gender-specific effects of dietary
phosphate supplementation or RNAi-knockdown. Thus, we
subsequently conducted life span tests using males.
To collect excretions sibling females fed different media at
18uC, 25uC or 29uC for 5 days were transferred to SM for
60 min., followed by a 60 min. collection of excretions in a 1.5 ml
vial. For hemoymph collections, female flies were anesthetized
with CO2, heads were removed, and fly bodies were centrifugated
at 5000 rpm for 3 min. at 4uC in a 200 ul eppendorf vial with
a punctured bottom, allowing for the collection of the clear, cell-
free hemolymph. For whole fly phosphate bodies were homoge-
nized in assay reagent. The excretion, hemolymph and whole fly
samples were then cleared by centrifugation and assayed for
phosphate concentration in 100 ul ammonium molybdate phos-
phate assay reagent (Phospho Liqui-UV, Stanbio 0851-250) at
340 nm.
Genome-wide Drosophila Cell-based RNAi Screen
(Primary Screen)
The genome-wide dsRNA screening collection of the Drosophila
RNAi Screening Center (DRSC) covering .95% of the Drosophila
genome has been described previously [25]. Approximately 14,000
genes were screened in S2R+ cells [26], using an in-cell
immunohistochemical assay for dual-phosphorylated ERK1/2
(Cell Signaling Technologies, Inc #CS4370), DAPI as counter
stain to correct for cell number, and 10 mM sodium phosphate as
the stimulus along with control as described in Methods S1 and
Figure S6A–C. The primary list of ‘‘hits’’ (positive results)
comprised 1924 genes, including 5 genes of the canonical MAPK
pathway (i.e. downstream of receptor kinase (drk), downstream of raf1
(Dsor1), ras85D, sos, corkscrew) and 11 genes that are known inputs
or effectors of MAPK (i.e. slipper, mushroom bodies tiny, protein tyrosine
phosphatase-ERK/enhancer of ras1, nemo, eiger, RH51659P, SD03870P,
CG32703-PA, CG14217-PD, sevenless, pointed). We excluded hits not
expressed in S2R+ cells and annotated the remaining genes for
molecular function, conservation, and other features by cross-
referencing with publicly-available databases i.e. DAVID [27], fly-
MINE [28] and by manually annotating the list. Our goal was to
retain genes that encode conserved proteins with known or
putative membrane-spanning molecules, as well as known or
putative receptors, kinases, phosphatases and transcription factors,
but to exclude genes required for routine basic cellular functions,
genes for which we could not detect known or putative human
orthologs, or genes previously identified as important for insulin-
mediated activation of MAPK [29]. A subset of 555 genes was
selected for validation using at least two independent dsRNA
amplicons per gene as described in the results section and Methods
S1 using 10 mM sodium phosphate buffer or with 50 ug/ml
human insulin as stimulus.
In vivo Drosophila RNAi Screen (Secondary Screen)
At least two independent transgenic RNAi-lines targeting 51 of
the 146 final hits were available (TRiP, http://www.flyrnai.org/
TRiP-HOME.html, VDRC, http://stockcenter.vdrc.at/control/
main) and crossed with temperature-regulated ubiquitous Gal80/
Gal4 driver stocks using the daughterless (da) promotor to drive Gal4
expression (w-, hs-hid(y)/w-;tub-Gal80ts20;da-Gal4; referred to as da-
Gal4ts), and confirmed using the alphaTub84B promotor (w-;tub-
Gal80ts10;tub-Gal4/TM6B; referred to as tub-Gal4ts)) [30].
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PLOS ONE | www.plosone.org 2 March 2013 | Volume 8 | Issue 3 | e56753
da-Gal4ts.UAS-RNAi animals were examined for larval lethal-
ity at 29uC, the inducing temperature. Adult males were reared at
18uC to keep the RNAi un-induced during development and used
within three days of eclosing for life span assays. Sibling females
were used for hemolymph phosphate assays as described above.
Life span of F1 males generated with control RNAi-lines targeting
the white gene (TRiP# HMS00017, VDRC #30034) at 29uC on
SM was 31+/21 days, and 35+/20.4 days, respectively, targeting
green fluorescence protein (GFP) (Bloomington ID # 35785) was
35+/21.4 days, and targeting luciferase (Luc) (TRiP # JF01355)
was 39+/22 days. Hemolymph phosphate of F1 generation
females targeting white (TRiP #HMS00017, VDRC #30034) was
25+/22.5 mg/dl and 31+/21.7 mg/dl, respectively, targeting
GFP (Bloomington ID # 35785) was 27+/22 mg/dl, and
targeting Luc (TRiP # JF01355) was 29+/22.4 mg/dl.
Off-target effects were unlikely, if results were reproducible by at
least two independent RNAi-lines and significant based on p,0.05
(Student’s t-test) across all RNAi-lines targeting a single gene when
compared to control hairpins targeting white, GFP and Luc. Genetic
background effects were unlikely since phenotypes were generally
absent in the uninduced state (18uC) (see Figs. S1A, S9).
Data Analysis
Median life span and maximum life span were calculated for
each vial of flies using Prism 5.0 d (GraphPad Software, CA),
averaged between multiple vials based on a total of 120–240 flies
of each genotype and medium. Student’s T-test (two-sided,
unequal variance) was then used to determine significant
differences between genetic mutants and treatment groups
(p,0.05). To correct for multiple comparisons we applied
Bonferroni’s method [31] to re-test outliers. Hierarchical cluster-
ing was performed in Cluster 3.0 [32] using Pearson correlation or
Euclidean distance, and displayed using Java TreeView 1.1.6 [33].
Final hits were annotated with GO term categories using the
DAVID tool (http://david.abcc.ncifcrf.gov/) [27], and FlyMine
(www.flymine.org/) [28]. Candidate human and murine orthologs
were obtained using DIOPT (http://www.flyrnai.org/cgi-bin/
DRSC_orthologs.pl) [34] and annotated with murine knockout or
over-expression phenotypes at MGI if available (http://www.
Figure 1. The effect of sevelamer and PFA on larval development is reversible by addition of 30 mM phosphate to the medium. A,
C: Number of larvae emerged from the medium. P30= standard medium supplemented with 30 mM sodium phosphate (pH 6.0), PFA=pho-
sphonoformic acid 0.1–10 mM, Sev = sevelamer 0.1–1%; Shown are means, CV,10%, B, D: Number of adults eclosed. Shown are means 6 SEM of
one representative experiment, performed in triplicate.
doi:10.1371/journal.pone.0056753.g001
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informatics.jax.org/) [35], and with human disease phenotypes
using DIOPT-DIST (http://www.flyrnai.org/cgi-bin/
DRSC_DG_query.pl) [34].
Results
Phosphate is Required for Drosophila Larval
Development
Culture of three commonly used laboratory fly strains, y w,
Canton S (CS) and Oregon R (OR), on standard medium (SM) or
SM supplemented with 30 mM sodium phosphate (P30) equally
supported larval development and eclosion of adult flies after 10
days at 25uC. To investigate the effects of phosphate on larval
development, we added phosphonoformic acid (PFA) to block
sodium-phosphate co-transporters and cellular uptake of phos-
phate [36]. Supplementation of SM with 0.1 mM PFA did not
result in developmental delay or lethality of y w flies. However,
developmental delay was noticeable in y w animals fed SM with
1 mM PFA and led to pupal lethality. Larvae reared on SM with
10 mM PFA died at the first instar stage unless the medium was
further supplemented with 30 mM sodium phosphate (Fig. 1A and
1B). Thus, we observed a dose-dependent response to PFA
Figure 2. Phosphate supplementation or inhibitors of phosphate uptake influences adult life span. Median life span of adult y w males
cultured on standard medium (SM): Control (C, n = 550), 30 mM sodium phosphate (P30, n = 465), 30 mM sodium sulfate (S30, n = 245), 1% sevelamer
(Sev1, n = 207), 1 mM phosphonoformic acid (PFA1, n = 130), and the combinations: Sev1+P30 (n = 115), PFA1+P30 (n = 137), or defined medium (DM)
supplemented with 1.5, 27, or 53 mM sodium phosphate (P1.5, n = 202; P27, n = 200; P53, n = 194). P,0.005 was used to test for multiple comparisons
between eleven treatments.
doi:10.1371/journal.pone.0056753.g002
Figure 3. Adult hemolymph phosphate, phosphate excretion and whole fly Pi. A: Excretion of phosphate after culture of y w females for
five days on standard medium (C) alone or supplemented with 1% sevelamer (Sev1%) and 30 mM sodium phosphate (P30) (n = 3 pooled collections
of 15–20 flies). B: hemolymph phosphate concentration (n = 3 pooled collections of 15 flies) and C: whole fly phosphate (n = 10) of flies cultured as
described for A. Note that y w and CS flies have lower hemolymph phosphate concentrations than OR and w1118 flies and the F1 generation females
that express control RNAis (see Methods and Fig. S5), which is likely due to differences in genetic background.
doi:10.1371/journal.pone.0056753.g003
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Figure 4. Principal cell ablation increases hemolymph phosphate and decreases life span, rescue by addition of sevelamer to the
culture medium. A, B: Micrographs of 10 days old males with expression of GFP (green) in principal cells (A) or females with expression of GFP
along with reaper (rpr) in principal cells after culture for ten days at 29uC (B). Epifluorescent microphotograph (10X) of tubule and gut of the same
Phosphate Response in Drosophila
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treatment that could be reversed by supplementation with dietary
phosphate. To confirm phosphate-dependence of larval develop-
ment we used the anion exchange resin sevelamer to inhibit
dietary uptake of phosphate [23]. When y w larvae were reared on
SM supplemented with 0.1% sevelamer, no effect on larval
development was observed. However, increasing the dose to 0.5%
delayed emergence of L3 larvae from the medium, puparation and
eclosion of adults by at least one day (Fig. 1C, Fig. S2). Similar to
what we found for PFA, the effect of sevelamer could be rescued
by supplementation with 30 mM sodium phosphate. A dose of 1%
sevelamer (Sev1%) resulted in a more severe developmental delay
that could be prevented by the addition of 30 mM sodium
phosphate. Similar results were obtained with the two wildtype
strains, CS and OR (Fig. S2), and males and females eclosed at
similar ratio after development on foods with different phosphate
contents.
Dietary Phosphate Affects Life Span of Adult Flies
Dietary phosphate modifies circulating phosphate levels and life
span in genetically modified mice [21,37,38] and humans with
CKD [19,20,39]. We next reared flies on SM and then placed F1
adults within 3 days of eclosing on experimental media to ask if
dietary phosphate could modify adult life span. The median adult
life span of y w males at 25uC was 4260.8, 3862.4 (p= 0.02 vs.
SM), and 4460.8 (not significant vs. SM) days when adults were
cultured on SM, P30, or 30 mM sodium sulfate (S30), respectively
(Fig. 2). Findings were similar for females (51.260.5, 39.262.6
(p = 0.04 vs. SM), and 46.860.2 (p = 0.01 vs. SM) on SM, P30,
and S30, respectively) and for CS and OR males (Fig. S3A). The
effects of phosphate were dose-dependent between 15 and 60 mM
(Fig. S3B).
If increasing phosphate levels through dietary availability results
in shortened life span, then conversely, reducing phosphate intake
might extend life span. Consistent with this idea Sev1% increased
median life span to 4961.9 days (p = 0.006 vs. SM and p= 0.003
vs. P30), an effect that was lost when we additionally supplemented
with 30 mM sodium phosphate. Similarly, adult life span was
extended to 4761.8 days (p = 0.03 vs. P30) when 1 mM PFA was
added to SM but not when adults were cultured on SM with both
1 mM PFA and 30 mM sodium phosphate. Neither phosphate,
nor sevelamer affected the rate of food consumption (Fig. S4A).
To further establish that the effect of sevelamer and PFA on
improving life span is not due to non-specific effects, we cultured
flies on Robert’s defined medium DM [22]. Although overall life
span was reduced on this medium, presumably as it lacks
components present in the more complex SM, we observed
statistically relevant differences when y w males, reared on SM,
were cultured on DM supplemented with phosphate for the
remainder of their life span. Specifically, we observed a significant
inverse relationship between life span and phosphate concentra-
tions (Fig. 2).
Since dietary phosphate levels influence life span, we asked
whether this effect is mediated by a change in hemolymph
phosphate levels, which in turn may cause extracellular mineral-
ization as seen in higher species or cellular toxicity [21,37,38,40].
When y w females are cultured on SM, Sev1%, and P30 for five
days, excretions directly reflect intake of phosphate (Fig. 3A).
However, the hemolymph phosphate concentration and whole fly
phosphate content of these flies were indistinguishable across all
culture conditions (Fig. 3B and 3C). Similar results were obtained
for w1118, CS and OR strains (Fig. S5). The ratio of phenol red
over FD&C blue1, food dyes [24] that measure urine and fecal
dye-excretion or fecal dye-excretion alone, respectively, indicated
that excess phosphate may simply travel through the gut and be
excreted in feces, and/or actively excreted into the gut following
uptake (Fig. S4C). The stability of hemolymph phosphate in the
face of wide variations in exposure of the organism to dietary
phosphate suggests strong homeostatic mechanisms maintaining
that stability.
genotypes shown in A+B. Ablation of GFP-positive cells (green) by rpr is nearly complete with the exception of a few segments as shown
schematically in the inset. As a consequence when compared to rpr-negative tubules (C), the majority of the tubule stained with propidium iodide
(red) is made up of GFP-negative cells in (D). Median life span (E, n = 60–120 per condition) or hemolymph phosphate concentration (F, n = 3 with
collections from 15 flies) of females expressing rpr or GFP-RNAi in principal cells after culture on standard medium containing 30 mM sodium
phosphate (P30) normalized when cultured on 1% sevelamer (Sev1%) for 14 days.
doi:10.1371/journal.pone.0056753.g004
Figure 5. RNAi-mediated inhibition of MAPK-signaling in vivo
decreases hemolymph phosphate. A: The most advanced de-
velopmental stage with induced knockdown was scored on standard
medium (1= embryonic, 2 = first and second instar larva, 3 = third instar
larva, 4 =pupal lethal, 4.5 = developmental delay, adult, 5 = adult). B:
hemolymph phosphate concentration of young adult females cultured
at 29uC for five days, and C: median life span of adult males cultured at
29uC on standard medium (see also Table S1). a: p,0.05, b: p,0.007 vs.
Luc/GFP/white controls. P,0.017 was used to test for multiple
comparisons between three treatments.
doi:10.1371/journal.pone.0056753.g005
Phosphate Response in Drosophila
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Adult Hemolymph Phosphate is Dependent on the
Function of the Malpighian Tubules
The kidneys in higher species are responsible for excretion of
phosphate in the setting of high dietary load and re-absorption of
phosphate from the urine when dietary supply of phosphate is low.
Malpighian tubules are the phylogenetic ancestor of the renal
tubes [41]. They are composed of two cell types: stellate cells,
which are important for water and chloride excretion, and
principal cells, which are important for the excretion of cations
and organic solutes. To determine the role of principal cells in
phosphate homeostasis, we expressed the pro-apoptotic gene reaper
(rpr) [42] using a urate-oxidase (Uro)-Gal4;tub-Gal80ts7 driver (Uro-
Gal4ts), which permits gene expression in a temperature-inducible
Figure 6. S2R+ genome-wide RNAi screen. A: heatmap of z-scores for 146 verified genes, cell count/well based on DAPI signal (first column),
dpERK signal after 10 min. phosphate stimulation (middle column), and dpERK signal after 10 min. insulin stimulation (third column), green indicates
positive regulators, red indicates negative regulators. B: Functional classification of 146 verified genes based on GO term categories using the DAVID
tool (http://david.abcc.ncifcrf.gov/) [27], and FlyMine (www.flymine.org/) [28]. C: Number of genes identified in prior DRSC screens.
doi:10.1371/journal.pone.0056753.g006
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fashion in principal cells. At the inducing temperature, epifluor-
escent and confocal analyses confirmed the near-total ablation of
GFP-positive cells by rpr when coexpressed in principal cells
(Fig. 4A, 4B). As a consequence, when compared to rpr-negative
flies (Fig. 4C), the majority of the tubule in rpr-positive flies is made
up of urate-oxidase negative cells in Figure 4D. Thereby impaired
function of principal cells resulted in a female life span of 3462.2
days on P30 medium (vs. 4260.9 days for control flies, p = 0.024).
Hemolymph phosphate in these flies was raised to 4262.3 mg/dl
(vs. 3360.7 mg/dl for control flies, p = 0.023) (Fig. 4F). Impor-
tantly, this effect could be overcome by the addition of 1%
sevelamer to the medium, resulting in lower hemolymph levels and
improved life spans (Fig. 4E). Taken together these findings
suggest that dietary phosphate increases hemolymph phosphate,
which inversely correlates with longevity, at least in the setting of
tubule failure. These results parallel what is observed in human
patients with CDK, who similarly have increased circulating
phosphate concentrations, and for whom blocking phosphate-
uptake from the diet with sevelamer can improve outcomes.
RNAi-mediated Inhibition of MAPK-signaling in vivo
Decreases Hemolymph Phosphate
Previously, we showed that activation of MAPK by phosphate is
evolutionary conserved in Drosophila S2R+ hemocyte-like cultured
cells and likely requires the function of major facilitator
superfamily (MFS) sodium-phosphate co-transporters [10] (Fig.
S7). When we decreased MAPK-signaling activity in vivo by RNAi-
mediated knockdown of drk/GRB2, Ras85D, phl/D-Raf and Dsor1/
MEK using da-Gal4ts for a relatively short period of five days,
hemolymph phosphate was decreased in adult flies (Fig. 5B).
Likewise, knockdown of corksrew (csw/SHP2), a phosphatase known
to stimulate RTK input into the MAPK pathway [43], and Sos
mildly reduced adult hemolymph phosphate. Therefore, hemo-
lymph phosphate is genetically downstream of MAPK signaling.
Knockdown of these genes also impaired larval development and
reduced longevity when ablated during adult life, with the
exception of csw/SHP2 whose knockdown during adult life
increased life span (Fig. 5A, 5C).
Figure 7. In vivo secondary screen using the da-Gal4ts as driver identifies genetic modifiers of Drosophila larval development, and
adult hemolymph phosphate and lifespan. A: Developmental stage on standard medium, B: hemolymph phosphate concentration of young
adult females cultured at 29uC for five days, and % change of life span on standard medium supplemented with 1% sevelamer (C), or 30 mM sodium
phosphate (D) when compared to standard medium alone (E) (see also Table S1).
doi:10.1371/journal.pone.0056753.g007
Phosphate Response in Drosophila
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Genome-wide RNAi Screen to Identify Modifiers of
Phosphate-induced MAPK in Drosophila Hemocyte-like
Cultured Cells
To identify novel components of the phosphate sensing pathway
and to further understand whether the MAPK pathway mediates
some of the phosphate effects observed on larval development,
adult life span and hemolymph phosphate, we adapted a high
throughput assay for MAPK activation in S2R+ cells [29] using
10 mM sodium phosphate as the stimulus and screened sixty-one
384-well plates with an average of 1.5 dsRNAs per gene in
duplicate to cover the entire fly genome (approximately 14,000
genes). We obtained 1924 primary hits (see Methods). A subset of
Figure 8. In vivo secondary screen using the tub-Gal4ts as driver identifies genetic modifiers of Drosophila larval development, and
adult hemolymph phosphate and lifespan. A: Developmental stage on standard medium, B: hemolymph phosphate concentration of young
adult females cultured at 29uC for five days, and % change of life span on standard medium supplemented with 1% sevelamer (C), or 30 mM sodium
phosphate (D) when compared to standard medium alone (E) (see also Table S1).
doi:10.1371/journal.pone.0056753.g008
Table 1. Significant outliers in development, life span, and hemolymph phosphate.
Assay Developmental lethal genes Life span of adults (longer, shorter) Hemolymph phosphate (higher, lower)
Genes CkIalpha, br, Hsc70-4, Hdac3, smo, Rbf,
penguin, emb, CG6218, CG7185, rut,
CG12703, RpL5, CG8993, dei, pAbp, Unr,
mask, Sin3A, Ptp69D, CG3446, CG13998
RhoBTB, rut, CG33087, CG17906, Tre1, Acon,
pyd3, Map205, RpL5, CG8993,
B52, CG3446, Unr, CG7185, pAbp,
emb, Hsc70-4
pyd3, CG31217, CG3446, pAbp, CG17906,
CG33087, Hsc70-4, nej,
Socs36E, drk, Dsor1
Drosophila gene names for developmental lethal mutants and outliers in life span and hemolymph phosphate assays shown in Figures 6 and 7. Significance for
longevity and hemolymph phosphate is based on Student’s t-test (p,0.05). Bold script indicates genes that remain significant after Bonferroni’s correction for multiple
comparisons when we used p,0.003 for the life span assay based on 17 outliers and when we used p,0.007 and p,0.0125 for the hemolymph assay based on seven
and four outliers, respectively. Underline script is used for longer/higher outliers, while regular script is used for shorter/lower outliers. (See Table S1 and Figs. 7, 8 for
detailed results).
doi:10.1371/journal.pone.0056753.t001
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555 genes was selected based on their expression in S2R+ cells,
annotation and conservation in the human genome. These were
re-screened in vitro using at least two independent dsRNAs
targeting different regions of the mRNA encoding these genes.
Further, as MAPK signaling is regulated by insulin signaling in
Drosophila cells, we reasoned that selecting candidate genes that
affect MAPK signaling under phosphate activation but not insulin
would enrich for ‘‘phosphate-selective’’ regulators. Of a total of
146 genes verified with phosphate as the stimulus 84 did not score
with insulin and are thus ‘‘phosphate-selective’’ in our assay
conditions (Fig. 6A). From the remaining 62 non-selective genes
we eliminated 43 ‘‘frequent hitters’’ in RNAi screens because they
were identified in more than three prior DRSC screens and
further evaluated 103 genes.
Subsets of Phosphate-selective Genes are Modifiers of
Larval Development, Life Span and Hemolymph
Phosphate in vivo
To determine the effect of these103 genes in vivo we tested
whether ubiquitous expression of RNAi constructs targeting these
genes affected viability and if so, whether viability could be
affected by dietary phosphate. Two or more RNAi lines were
available from the TRiP and VDRC for 51 genes (including 40
‘phosphate-selective’). Viability tests were initially done using da-
Gal4ts (Fig. 7) and a subset verified using tub-Gal4ts (Fig. 8).
When cultured at the inducing temperature of 29uC, knock-
down of 22 genes resulted in lethality at or before puparation
(Table 1, Fig. 7A). Lethality could not be rescued by supplemen-
tation of the media with 30 mM sodium phosphate (not shown).
When reared at 18uC to keep the RNAi un-induced development
was normal for most genes (Fig. S1A). When knockdown was
induced within three days of eclosing ten genes prolonged median
life span in adult males, when compared to control hairpins, while
knockdown of seven genes reduced median life span (Table 1,
Fig. 7E). RNAi knockdown of some genes furthermore influenced
the life span responses to dietary phosphate, albeit non-
significantly (Fig. 7C, 7D). Knockdown in young sibling females
for five days identified seven negative regulators of hemolymph
phosphate levels (i.e. knockdown resulted in increased levels),
whereas knockdown of four genes resulted in decreased hemo-
lymph phosphate (Table 1, Fig. 7B).
Discussion
Using a cell-based MAPK assay, we identified 146 genes that
are candidate positive and negative regulators of MAPK activation
by phosphate in vitro. Among these are drk/GRB2, sos, csw/SHP2,
Ras85D, dos/Gab2, and dsor1/MEK, confirming that the assay
identified known members of the canonical MAPK-pathway. 61
(41%) of these genes had been identified in three or fewer of .40
genome-wide RNAi screens performed previously at the DRSC
(Fig. 6C). Furthermore, non-selective genes verified in the current
screen overlapped significantly with those identified in a previous
RNAi screen for insulin-induced MAPK using S2R+ cells [29],
supporting the idea that our approach selected for genes specific
for the MAPK-pathway. Interestingly, knockdown of the 84
‘phosphate-selective’ genes had little or no effect on cell number as
indicated by a total fluorescence assay of cell number (Fig. 6A),
whereas knockdown of most ‘non-selective’ regulators over 4 days
reduced or increased cell number of the screening cell line. This
finding may indicate that the ‘phosphate-selective’ set is enriched
for genes distinct from the canonical MAPK pathway, which is
known to regulate cell proliferation. Based on annotations, these
genes have possible roles upstream of MAPK, as receptors,
pathway components, or transcription factors (Fig. 6B). Finally,
most are expressed ubiquitously, as expected for a metabolic
phosphate sensing pathway (see cluster analysis based on
expression data available in FlyAtlas [44] in Fig. S8).
We next demonstrated that larval development, hemolymph
phosphate and adult life span are dependent on dietary phosphate.
Dietary phosphate is required for larval development, while too
much dietary phosphate reduces longevity of adult flies. Further,
perturbation of the Malpighian tubules, the phylogenetic ancestor
of renal tubules, in adult flies recapitulates some of the findings of
CKD and elevates hemolymph phosphate and causes premature
death. In addition, hyperphosphatemia resolves and life span is
normal when these flies are cultured on medium supplemented
with sevelamer that prevents absorption of phosphate from the
diet. Finally, RNAi-mediated inhibition of MAPK-signaling affects
larval development, and adult life span and hemolymph
phosphate, raising the possibility that some in vivo effects involve
activation of this signaling pathway by phosphate.
When characterizing 51 modifiers of activation of MAPK by
phosphate in vitro we found that knockdown of 21 also affected
larval development, adult hemolymph phosphate or life span
(Table 1). Furthermore, knockdown of 15 genes had an effect
consistent with the effect of knockdown of core pathway
components Ras85D, phl/D-Raf or Dsor1/MEK in vivo. These genes
are candidates that may link phosphate sensing to the MAPK
pathway. Based on published literature the identified genes and
their mammalian orthologs functionally group into 1) modifiers of
MAPK-signaling (embargoed (emb) [45,46,47], multiple ankyrin repeats
single KH domain (MASK) [48,49]), 2) targets of phosphate (Upstream
of N-ras (Unr) [50,51,52,53,54,55], and Trapped in endoderm 1 (Tre1)
[56]), 3) oxidative stress and aging (Heat shock protein cognate 4
(Hsc70-4) [57,58], CG8993 [59,60], Aconitase (Acon) [61,62],
CG3446 [63], B52 [64,65]) and 4) skeletal growth and differen-
tiation (Smoothend (Smo) [66], CG33087 (LRP1) [66], Casein kinase 1
alpha (CkIalpha) [66], Histone deacetylase 3 (Hdac3) [67,68,69],
Retinoblastoma-family protein (Rbf) [70,71], Ribosomal protein L5
(RpL5) [72,73]). Future analysis will help determine whether they
function upstream of MAPK or modify phosphate toxicity.
Mammalian orthologs, if found to have similar roles, may facilitate
the development of novel approaches to the management of
hyperphosphatemia, for example in patients with CKD.
In summary, we established Drosophila melanogaster as a model
system to study phosphate. By combining cell-based and in vivo
RNAi-screening we identified a number of genes with putative and
previously unrecognized roles in metabolic and homeostatic
phosphate sensing.
Supporting Information
Figure S1 Developmental phenotypes. A: Latest larval
stage observed for F1 offspring generated in matings between 268
UAS-RNAi males and virgin w-;tub-Gal80ts20;da-Gal4 females when
cultured on standard medium at 18uC (non-inducing tempera-
ture). B: Latest larval stage observed for F1 offspring generated as
described for (A) with the same genetic crosses on standard
medium at 29uC (inducing temperature).
(TIF)
Figure S2 The effect of sevelamer and PFA on larval
development by developmental stage. Shown is larval
development of three wild-type strains: y w (YW), Oregon R
(OR) and Canton S (CS) on control (C), P30, Sev1% and PFA
1 mM medium. Abbreviations as follows: ML, migrating instar 3
larva; PP, prepupa; P, pupa; M, adult male; F, adult female.
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Shown is one representative experiment with cumulative fly
counts, means of three vials per condition.
(TIF)
Figure S3 Effect of phosphate, sevelamer and PFA on
adult life span. A: Median life span of Canton S (CS) and
Oregon R (OR) wild type males on standard medium or SM with
30 mM sodium phosphate or 1% sevelamer (CS: C, n = 155; P30,
n = 62; Sev1, n= 58, OR: C, n= 117; P30, n= 52; Sev1, n = 59).
B: Median life span of y w males on standard medium,
supplemented with 15, 30 and 60 mM sodium phosphate (C,
n = 550; P15, n = 282; P30, n= 465; P60, n= 115). To correct for
the influence of osmolarity, life spans for P15, P30, and P60 are
displayed as % of life spans for 15, 30, and 60 mM sodium sulfate,
respectively.
(TIF)
Figure S4 Dye uptake and excretion. A: Uptake of food
dyes within 60 min. B: Dye excretion over 60 min. after flies were
loaded with food dyes over night. C: Ratio of amount of dyes
present in excretions (theoretical ratio 5.2 from fresh food is
indicated by blue line).
(TIF)
Figure S5 Adult hemolymph Pi, Phosphate excretion
and whole fly Pi. Young adult w1118, Canton S or Oregon R
females were cultured on standard medium alone or SM
supplemented with 30 mM sodium phosphate (P30), or 1%
sevelamer. Following culture for 5 days at 25uC, phosphate
excretion was determined (A)(n = 3, 20 flies each), and hemolymph
phosphate (B) (n = 3) and whole fly phosphate (C) (n = 10
individual flies) were measured.
(TIF)
Figure S6 Genome-wide RNAi screen (Controls). 20,000
S2R+ cells/384 well were treated with 0.375 ug dsRNA
targeting Lac-Z, Ras85D, Dsor1/MEK, Rho1 and thread
(A, primary screen) or LacZ, drk/GRB2, and Tao-1 (B,
secondary screen)/well as described in materials and methods.
After four days 10 mM phosphate (P10) (A, B), 50 ug/ml human
insulin (C) or 30 uM of the MEK-inhibitor UO126 (UO126) were
added for 10 min., followed by fixation and antibody staining for
dpERK and cellular staining with Dead Red or DAPI and
detection of total fluorescence with the appropriate filter sets.
Ratios of dpERK signal over cell Dead Red or nuclear DAPI stain
were expressed after subtraction of well background and
wandering-median correction across each 384-well plate as z-
scores.
(TIF)
Figure S7 P-induced ERK activation in murine and
Drosophila cells is blocked by RNAi-knockdown of
sodium-phosphate co-transporters and members of the
canonical MAPK pathway. RNAi knockdown in S2R+ cells
using dsRNA targeting luciferase (luc), insulin receptor (IR), two
sodium-phosphate co-transporters (MFS10 and MFS13), or
various components of the canonical MAPK pathway was
performed for three days prior to challenge with 10 mM sodium
phosphate (pH7.4) or 25 ug/ml Insulin for 3 min. Immunoblot
analysis of cell lysates was performed with anti-dpERK antibody,
converted into percent-stimulation (mean+/2 SD of three
independent experiments).
(TIF)
Figure S8 Tissue distribution of genes indentified in the
primary screen. Available expression data for all 146 genes
were downloaded from Fly Atlas [44], normalized by gene and
hierarchically clustered using Cluster 3.0 [32] and displayed using
Java TreeView 1.1.6 [33]. Red indicates high, green low
expression.
(TIF)
Figure S9 Temperature dependence of RNAi-effects on
hemolymph Phosphate and adult life span. A:Hemolymph
phosphate after culture of F1 offspring at inducing temperature
29uC (orange bars), and 18uC (blue line) for 63 RNAi-lines,
control hairpins are shown in light orange, mean+/2SEM. B, C:
Median life-spans of 118 and 68 RNAi-lines at inducing
temperature 29uC (orange bars) and 18uC (blue line)
(TIF)
Table S1 Annotations of 146 validated genes.
(XLSX)
Methods S1 Supplemental methods.
(DOCX)
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